Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be

From the ∗Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology, and Reproductive Sciences

†Shu Chien-Gene Lay Department of Bioengineering, University of California San Diego

‡Sanford Consortium for Regenerative Medicine, La Jolla, CA.

Correspondence: Marianna Alperin, MD, MS. E-mail: [email protected].

This study received funding from R01 HD102184 (K.L.C. and M.A.) and R01 DK128639 (K.L.C. and M.A.).

T.H. has declared that there are no conflicts of interest.

K.L.C. is a co-founder, consultant, and board member, and holds equity interest in Ventrix Bio, Inc.

M.A. receives editorial stipend from the American Journal of Obstetrics and Gynecology.

留言 (0)

沒有登入
gif